www射-国产免费一级-欧美福利-亚洲成人福利-成人一区在线观看-亚州成人

AstraZeneca to build $200m center in China

Updated: 2011-10-12 09:56

By Ma Zhenhuan (China Daily)

  Comments() Print Mail Large Medium  Small 分享按鈕 0

AstraZeneca to build $200m center in China

AstraZeneca PLC workers load blister strips onto a packing line at a factory in Macclesfield, United Kingdom. The UK-based medical company will create 600 jobs by building a new factory in Taizhou, Jiangsu province. [Photo / Bloomberg]

SHANGHAI - AstraZeneca PLC, one of the world's leading pharmaceutical companies, said it would invest $200 million to launch a new manufacturing facility in China to meet growing demand, including in rural areas.

Construction work on the project, in the China Medical City in Taizhou of East China's Jiangsu province, is scheduled for completion by the end of 2013, creating approximately 600 jobs.

This will be London-based AstraZeneca's largest single investment in a manufacturing facility globally. The new plant will produce intravenous and oral solid products, the company said.

"The new facility will significantly enhance our capacity and allow us to meet the growing healthcare demand of the Chinese population, and help us expand into the 900 million (rural) people outside of the big cities and hospitals," Mark Mallon, president of AstraZeneca China, told China Daily in an exclusive interview on Monday.

"It will also allow us to free up some capacity at our existing manufacturing facility in Wuxi, Jiangsu, to bring on more new innovative products that will be launched over the next few years," he added.

The Chinese pharmaceutical market grew from $10 billion in 2004 to $41 billion in 2010, according to market research agency IMS Health Inc, and it is expected to reach $102 billion by 2015.

Mallon said that he believes the Chinese government's focus on healthcare reform and investment in improving healthcare infrastructure and expanding insurance coverage will continue to drive the company's business growth and increase access to quality medicines over the longer term.

AstraZeneca will launch two new products, Faslodex, a treatment for breast cancer, and Onglyza, a new treatment for Type-2 Diabetes, in China this year.

Mallon also mentioned that the company is planning to launch Brilinta, an oral antiplatelet treatment for acute coronary syndrome, next year in China.

With an enhanced manufacturing capacity and the launch of more innovative new medicines, the company is planning to produce more affordable medicines for Chinese patients. It will adopt a multi-channel approach to sell its products to markets beyond big cities and hospitals.

Aside from the medical sales representatives who deal with individual physicians in big cities, the company has developed a team of about 100 customer service representatives who organize educational programs for small clinics and community health centers in China's rural areas.

It will also set up an inbound and outbound call center to reach out to healthcare professionals through phone calls, helping them learn more about AstraZeneca products, he said.

The company, which entered China in 1993, has invested about $500 million in the country, including an innovation center in Zhangjiang, Shanghai.

主站蜘蛛池模板: 日本手机在线视频 | 三级黄色毛片网站 | 欧美性色网 | 国产精品自拍视频 | 国产成人精品永久免费视频 | free性欧美hd另类精品 | 国产一区二区三区视频 | 国产aaa女人十八毛片 | 性做久久久久免费观看 | 日本免费二区三区久久 | 最新精品国产 | 精品久久久中文字幕二区 | 国产成人综合日韩精品无 | 女仆色在线 | 中文字幕在线精品 | 亚洲精品在线免费观看视频 | 欧美一区二区在线视频 | 久久久综合结合狠狠狠97色 | yy毛片 | 日本一极毛片兔费看 | 毛片毛片毛是个毛毛片 | 欧美日本综合一区二区三区 | 国产一级做a爱片久久毛片a | 精品视频免费在线 | 欧美成人影院在线观看三级 | 日韩精品福利视频一区二区三区 | 日本免费在线视频 | 香港全黄一级毛片在线播放 | 久在线视频 | 亚洲一区www| 九九精品免视看国产成人 | 黄到让你下面湿的视频 | 亚洲 欧美 手机 在线观看 | 一级毛片aaaaaa视频免费看 | 91精品最新国内在线播放 | 成人免费网站久久久 | 国产在线精品香蕉综合网一区 | 男人的天堂毛片 | 国产一区二区三区精品视频 | 亚洲精品精品 | 国产三级日产三级日本三级 |